Isolation of the intracellular and extracellular polysaccharides of Ganoderma neojaponicum (Imazeki) and characterization of their immunomodulatory properties
Reprint PDF

Keywords

extracellular polysaccharide
Ganoderma neojaponicum (Imazeki)
immunomodulatory properties
intracellular polysaccharide

How to Cite

1.
Ubaidillah NHN, Abdullah N, Sabaratnam V. Isolation of the intracellular and extracellular polysaccharides of Ganoderma neojaponicum (Imazeki) and characterization of their immunomodulatory properties. Electron. J. Biotechnol. [Internet]. 2015 May 27 [cited 2024 Oct. 5];18(3). Available from: https://www.ejbiotechnology.info/index.php/ejbiotechnology/article/view/2015.03.006

Abstract

The role of polysaccharides isolated from the Ganoderma species of fungi in innate immunity has recently become a topic of research. Although some work has been conducted concerning Ganoderma lucidum, the characteristics of polysaccharides isolated from Ganoderma neojaponicum (Imazeki) as immunomodulatory agents are largely unknown. The aims for this study were to isolate and characterize the intracellular polysaccharides (IPSs) and extracellular polysaccharides (EPSs) of G. neojaponicum from STR reactor. The production of EPS and IPS were optimized on day 4 of the cultivation time in 2L STR reactor based on amount of biomass yield, total carbohydrate, β-glucan and α-glucan content. Further analysis, both the EPSs and IPSs showed the enhancement on proliferation and increment of phagocytosis activities of macrophage (RAW264.7) cell lines. Using an oral toxicity test, we also observed that 2000 mg/kg body weight/day dosage of dried G. neojaponicum mycelium does not cause any significant toxic effects on Sprague-Dawley rats in 14 d of administration. Thus, the polysaccharide from G. neojaponicum has the potential to be further commercially explored as an alternative for medicinal Ganoderma variety of G. lucidum production.

Reprint PDF

Upon acceptance of an article by the journal, authors will be asked to transfer the copyright to Electronic Journal of Biotechnology, which is committed to maintain the electronic access to the journal and to administer a policy of fair control and ensure the widest possible dissemination of the information. The author can use the article for academic purposes, stating clearly the following: "Published in Electronic Journal of Biotechnology at DOI:10.2225/volXX-issueX-fulltext-XX".

The Copyright Transfer Agreement must be submitted as a signed scanned copy to biotec@ucv.cl. All authors must send a copy of this document.